Radiation Oncology for Pediatric CNS Tumors

¿Part I: Basic Priciples:

Historical Perspective

Epidemiology

Pathology

Radiology

Neurosurgery

Chemotherapy

Part II: Embryonal Brain Tumors:

Medulloblastoma

SPNET

ATR/ETANTR (EMTR)

Part III: Ependymoma

Part IV: Glial Tumors:

Low Grade Glioma

Optic Pathway

High Grade Glioma

Brainstem Glioma

Craniopharyngioma

Part V: Germ Cell Tumors:

Germinoma

NGGCT

Part VI: Miscellaneous Tumors:

CNS Leukemia

Retinoblastoma

Spinal Tumors

Choroid Plexus Carcinoma

Skull Base Tumor

Pituitary Tumors

Brain Mets

Part VII: Radiotherapy Practice:

Immobilization

Image Guidance

Conformal RT

Particle Therapy

Craniopsinal Irradiation

Radiosurgery and HFRT

Re-irradiation

Part VIII: Radiotherapy Toxicity and Management:Neurocognitive

Endocrine

Vision

Hearing

Vascular and Brain

Susequent malignancy

Ethics of Treating Young Children

Dr. Mahajan is a Professor at the Mayo Clinic in Rochester, Minnesota since 2017.  She serves as the Clinical Director of Particle Therapy in the Department of Radiation Oncology.  In this role, she oversees the day to day operations of the center and is  heavily involved in planning future upgrades. Upon completing her residency training in Montreal, Canada and a fellowship in proton therapy at Massachusetts General Hospital, Dr. Mahajan joined the faculty at Tufts New England Medical Center.  Dr. Mahajan worked at MD Anderson Cancer Center for 15 years where she was the Section Chief for the Pediatric and CNS Radiation Oncology service.  She had also served as the Proton Therapy Medical Director and the Associate Residency Program Director.Dr. Mahajan's clinical interests have been in radiation oncology for children, adult CNS tumors, particle therapy and other advanced technologies.  During her time in Houston, she developed a robust pediatric proton practice, lead many research initiatives which resulted in over a sixty publication and several ongoing collaborations. Currently she is involved in advanced radiation therapy planning outcomes for proton therapy which will increase planning accuracy, delivery with biologic dose evaluation.Dr. Paulino is a Professor of Radiation Oncology and Director of Pediatric Radiation Oncology at the MD Anderson Cancer Center. He did his residency in Chicago, Illinois and did a one year pediatric radiation oncology fellowship at St. Jude Children's Research Hospital. He has been treating childhood cancer for more than 25 years. His main research interest is understanding how radiotherapy can be used while minimizing late effects. He is an author of more than 200 peer-reviewed articles and more than 40 book chapters, mostly on pediatric cancer.

"The purpose is to provide up-to-date information on the epidemiology and management of brain tumors in children. ... this book meets its objectives and is a worthwhile and timely addition to the field. ... the intended audience is the pediatric oncology community ... ." (Karen Jean Marcus, Doody's Book Reviews, February, 2018)